Health ❯ Healthcare ❯ Pharmaceuticals

Clinical Trials

Drug Development Weight Loss Drugs Drug Efficacy Cancer Treatments Alzheimer's Disease Drug Safety Phase 3 Trials Cancer Treatment Obesity Treatments Obesity Treatment

Amylyx’s Avexitide Cuts Severe Low‑Blood‑Sugar Events 55% in Phase 3 Trial

A successful regulatory review would deliver the first FDA‑approved therapy for post‑bariatric hypoglycemia.

AstraZeneca Stops Phase III Volrustomig Lung Cancer Trial

AbCellera’s Menopause Antibody Hits Phase 2 Goals

Pfizer’s Oral Drug Shows Strong Phase 3 Results in Nonsegmental Vitiligo

Kalshi Opens Betting Markets for Phase 3 Drug Trials and FDA Decisions

Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows

EMA Opens Rolling Review as U.S. Hospitals Start Early Access to Daraxonrasib

Mineralys Secures Global Rights to Lorundrostat and Lines Up $650 Million in Capital

FDA Grants Priority Review to Roche’s Enspryng for Thyroid Eye Disease

Ocular Therapeutix Plans Q4 Filing for AXPAXLI After Reported FDA Alignment

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

Abivax Drug Shows Breakthrough Ulcerative Colitis Results as Shares Plunge After Cancer Cases

Ivonescimab Shows Two‑Year Survival Gain in China Phase 3 Trial

Daraxonrasib Doubles Survival in Second‑Line Metastatic Pancreatic Cancer

Bepirovirsen Achieves Functional Cure in About One in Five People With Chronic Hepatitis B

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

Apnimed Pill Cuts Sleep Apnea Events in Phase 3 as Company Seeks FDA Approval

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

Kissei Discloses 20 Deaths in Japan Among Tabneous Users

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke